Long Acting Injectable PrEP & Women- A Conversation About HPTN 084
Join Sinead Delany-Moreltwe, the PI of HPTN 084 in a conversation about the ongoing clinical trial of long-acting PrEP. Dr. Delany-Moreltwe will discuss a range…
Join Sinead Delany-Moreltwe, the PI of HPTN 084 in a conversation about the ongoing clinical trial of long-acting PrEP. Dr. Delany-Moreltwe will discuss a range…
August 20, 2020 3.00pm – 4:00pm EAT | 2:00pm– 3:00pm SAT Amidst the urgency to address global health challenges, the safety and rights of participants…
During the COVID-19 outbreak the Tangerine clinic, the first transgender-led clinic in Thailand, has adapted many of the health services offered to an online model. This pivot has included providing online tutorials and support for personal sample collection and medication delivery. Our speaker, Rena Janamnuaysook, will discuss these adaptations as well as strategies to build and support stakeholder engagement programs with key populations.
Check out the Community of Practice Group for more resources!
Globally, research teams are embarking on various clinical trials focused on finding a COVID-19 vaccine. However, efforts to
find a vaccine are characterized by misinformation, anti-vaccine sentiments, conspiracy theories, general distrust, or safety
concerns.
Growing evidence shows that these challenges lead to serious public health consequences, including vaccine hesitancy, increased
public fear and low in vaccine confidence. These challenges may lead to lower vaccine acceptability when the COVID-19 vaccine
becomes available. During this webinar, experts will unpack the determinants of vaccine hesitancy and how it can serve as
a barrier to uptake of the COVID-19 vaccine. They will also share strategies that can be used by advocates and community
engagement practitioners in response to misinformation, rumours, in order to build and sustain vaccine confidence.
During this participatory session participants will learn more about:
Why communicating clearly matters, with a focus on disseminating research study results
How to communicate and contextualize clear messages about research studies
How to prevent and manage a crisis
Transgender people are disproportionally impacted by HIV globally, yet are underrepresented in clinical HIV prevention trials. Beyond safety and efficacy data, there is also a…
In collaboration with the Advocate's Corner at HIVR4P, this webinar will introduce the basic concepts of a broadly neutralizing antibody, the rationale for using it…
This webinar will review the pipeline of products preventing HIV pregnancy, and other STIs, and review progress integrating sexual & reproductive health with HIV prevention services. Participants will be able to meet others interested in SRH/HIV integration and identify the role MPTs can play. The webinar will also provide an update on plans for the development and introduction of a new multi-purpose prevention technology - the Dual Prevention Pill (DPP) - for prevention of pregnancy and HIV acquisition in high-need countries.
CASPR, BAI, & TAG present a limited research engagement series discussing foundational concepts in next-generation clinical trial designs. The series explores t the science underpinning…